Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug
Motley Fool
Saturday, April 16, 2011 - 12:20pm
tags:
Amylin, Alkermes, diabetes, Eli Lilly, Bydureon
Advaxis: Collaboration with Wistar Institute Explores new Opportunity
Yahoo/Zacks
Saturday, April 16, 2011 - 12:19pm
tags:
Advaxis, fibroblast activation protein, cancer
Insulin patch developer Calibra raises $8.1M, including $1M in canceled debt Read more: Insulin patch developer Calibra raises $8.1M, including $1M in canceled debt
bizjournals.com
Saturday, April 16, 2011 - 12:18pm
tags:
Calibra, insulin patch, diabetes
[video] The Next Big Thing In Biotech: Earnings
TheStreet.com
Friday, April 15, 2011 - 11:31am
tags:
biotech, earnings, Amgen, Gilead Sciences, Biogen Idec, Alexion
Adeona Zinc Tab Fails to Aid Alzheimer's Patients
TheStreet.com
Friday, April 15, 2011 - 11:30am
tags:
Adeona, Alzheimer's disease, reaZin
Such A Deal! SuperGen & Its Growth Strategy
Pharmalot
Friday, April 15, 2011 - 11:28am
tags:
Supergen
Glaxo Plans to Sell Alli Diet Pill, 18 Other Consumer Brands
Bloomberg
Friday, April 15, 2011 - 11:24am
tags:
GSK, Alli, diet drugs
Earnings Preview: Abbott Labs
Yahoo/Zacks.com
Friday, April 15, 2011 - 11:23am
tags:
earnings, Abbott Laboratories
Merck Eases Investors’ Minds, At A Cost
Forbes
Friday, April 15, 2011 - 11:19am
tags:
Merck, investors
Boehringer’s Pradaxa Blood-Thinner Beats Bayer to EU Opinion
Bloomberg
Friday, April 15, 2011 - 11:19am
tags:
Boehringer Ingelheim, Pradaxa, blood thinners, Bayer, Europe
Drugmakers Poised to Report Biggest Profit Drop Since 2006 on Patent Loss
Bloomberg
Friday, April 15, 2011 - 11:18am
tags:
patents, generics
Biogen Test Finds Tysabri Patients With 1% Brain Disease Risk
Bloomberg
Friday, April 15, 2011 - 10:36am
tags:
Biogen Idec, Tysabri
What We Like for ASCO 2011
Seeking Alpha
Friday, April 15, 2011 - 10:35am
tags:
ASCO, Provectus, Celldex, Pharmacyclics, Keryx
Pfizer Says Arthritis Drug Candidate Cut Symptoms in Study
Bloomberg
Friday, April 15, 2011 - 10:26am
tags:
Pfizer, tofacitinib, rheumatoid arthritis
Merck Keeps Limited Rights to Share of J&J’s Sales of Remicade Medicine
Bloomberg
Friday, April 15, 2011 - 9:48am
tags:
JNJ, Remicade, Merck
Amarin: Positive ANCHOR Trial Data May Be Already Baked Into Its Price
Seeking Alpha
Friday, April 15, 2011 - 9:46am
tags:
ANCHOR, Amarin, GSK, dyslipidemia, AMR101
Human Genome Sciences Will Be Profitable, Eventually
Motley Fool
Thursday, April 14, 2011 - 10:33pm
tags:
Human Genome Sciences, GSK, Benlysta, Bayer, ONYX Pharmaceuticals, Elan, Biogen Idec
Cubist 1Q profit rises on Cubicin sales
Yahoo/AP
Thursday, April 14, 2011 - 10:31pm
tags:
Cubist Pharmaceuticals, earnings
Earnings Preview: Forest Labs
Yahoo/Zacks.com
Thursday, April 14, 2011 - 10:30pm
tags:
earnings, Forest Labs
Lilly To Keep Buying Companies As Patents Expire
CNBC
Thursday, April 14, 2011 - 10:27pm
tags:
Eli Lilly, M&A

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.